A recent study found that cytomegalovirus (CMV) reactivation is a significant complication among CMV-seropositive patients who undergo chimeric antigen receptor (CAR) T-cell therapy.

Read More> https://multiplemyeloma.pocn.com/patient-management/study-highlights-high-risk-of-cytomegalovirus-reactivation-in-patients-treated-with-car-t-cell-therapy/